Inventor · disambiguated record
George Mark
Also filed as: MARK GEORGE · MARK GEORGE E · MARK III GEORGE E
13 granted patents·9 pending applications·385 citations·filing 1990–2023
92Inventor score
Files withMERCK & CO INC7LUDWIG INST FOR CANCER RES LTD6RITTER GERD3JOHNS TERRANCE GRANT2INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NAT ACADEMY OF SCIENCE OF UKRANE1
Top patents by PatentIndex Score
22 records- 0197US6797492B2Method for reducing the immunogenicity of antibody variable domainsMERCK & CO INC·Filed 2001·Granted Sep 28, 2004·261 cites·3 claims
- 0292US8603474B2Membrane transporter NaPi2b (SCL34A1) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapyRITTER GERD·Filed 2009·Granted Dec 10, 2013·27 cites·11 claims
- 0387US9072798B2Specific binding proteins and uses thereofRITTER GERD·Filed 2010·Granted Jul 7, 2015·8 cites·25 claims
- 0484US2024117073A1Methods of treating neoplastic astrocytomaLUDWIG INST FOR CANCER RES LTD·Filed 2023·Application pending·0 cites
- 0578US9045533B2Membrane transporter NaPi2b (SCL34A2) epitope antibodiesRITTER GERD·Filed 2013·Granted Jun 2, 2015·3 cites·8 claims
- 0676US6280740B1Formulations of recombinant papillomavirus vaccinesMERCK & CO INC·Filed 2000·Granted Aug 28, 2001·4 cites·3 claims
- 0771US2021032366A1Methods of treating neoplastic astrocytomaLUDWIG INST FOR CANCER RES LTD·Filed 2020·Application pending·0 cites
- 0866US5189019AAntistasin derived anticoagulant proteinMERCK & CO INC·Filed 1990·Granted Feb 23, 1993·37 cites·3 claims
- 0961US2018057606A1Methods of treating meningiomaLUDWIG INST FOR CANCER RES LTD·Filed 2017·Application pending·0 cites
- 1061US2014322130A1Specific binding proteins and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2014·Application pending·0 cites
- 1159US2004253645A1Method for reducing the immunogenicity of antibody variable domainsFiled 2004·Application pending·0 cites
- 1258US5830849AVampire bat salivary plasminogen activatorsSCHERING AG·Filed 1995·Granted Nov 3, 1998·16 cites·38 claims
- 1355US2016046726A1Specific binding proteins and uses thereofLUDWIG INST FOR CANCER RES LTD·Filed 2015·Application pending·0 cites
- 1453US10385138B2Antibodies directed to membrane transporter NaP12b (SLC34A2) and uses thereof in cancer therapyINSTITUTE OF MOLECULAR BIOLOGY AND GENETICS NAT ACADEMY OF SCIENCE OF UKRANE·Filed 2017·Granted Aug 20, 2019·0 cites·9 claims
- 1553US9701755B2Membrane transporter NaPi2b (SCL34A2) epitope for antibody therapy, antibodies directed thereto, and target for cancer therapyLUDWIG INST FOR CANCER RES LTD·Filed 2015·Granted Jul 11, 2017·0 cites·13 claims
- 1651US6743622B2Homologous recombination antibody expression system for murine cellsMERCK & CO INC·Filed 1996·Granted Jun 1, 2004·7 cites·19 claims
- 1751US2011313230A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 1846US5795754ASynthetic HPV11 virus-like particlesMERCK & CO INC·Filed 1996·Granted Aug 18, 1998·14 cites·1 claims
- 1942US2011293511A1Specific binding proteins and uses thereofJOHNS TERRANCE GRANT·Filed 2011·Application pending·0 cites
- 2040US5738853ASynthetic HPV11 virus-like particlesMERCK & CO INC·Filed 1996·Granted Apr 14, 1998·7 cites·1 claims
- 2137US2011076232A1Specific binding proteins and uses thereofLUDWIG INST CANCER RES·Filed 2010·Application pending·0 cites
- 2235US6750041B2Homologous recombination antibody expression system for murine cellsMERCK & CO INC·Filed 1997·Granted Jun 15, 2004·1 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when George Mark files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →